Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
89.6 CHF | -0.44% | +4.76% | +5.57% |
08:14am | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.57% | 201B | |
+26.08% | 653B | |
+26.67% | 556B | |
-6.55% | 354B | |
+20.38% | 331B | |
+3.82% | 296B | |
+12.85% | 233B | |
-9.61% | 193B | |
-6.32% | 144B | |
-11.97% | 143B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis, Alnylam Pharmaceuticals Partner to Develop Liver-Targeted Therapy